US Stock MarketDetailed Quotes

LVTX LAVA Therapeutics

Watchlist

2.430
-0.210-7.95%

Trading May 28 15:51 ET

63.89MMarket Cap-2292P/E (TTM)

LAVA Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

(Q2)Jun 30, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

86.50%-1.13M

-1,063.94%-38.97M

-128.32%-10.12M

48.05%-7.45M

-34.41%-13.07M

-9.27%-8.34M

114.11%4.04M

580.70%35.74M

-75.40%-14.34M

-13.87%-9.72M

Net income from continuing operations

96.51%-484K

-31.70%-41.7M

56.65%-6.44M

-993.79%-8.79M

-56.95%-12.6M

-42.06%-13.87M

24.98%-31.66M

-81.92%-14.85M

114.27%983K

-8.09%-8.03M

Operating gains losses

-169.48%-658K

148.31%1.41M

-52.06%1.84M

54.99%-1.13M

92.22%-244K

185.16%947K

-43.28%-2.92M

389.81%3.84M

-53.63%-2.52M

-506.22%-3.14M

Depreciation and amortization

-21.09%247K

63.64%1.28M

29.89%352K

89.29%318K

69.54%295K

86.31%313K

39.96%781K

88.19%271K

11.26%168K

29.85%174K

Deferred tax

2.82%-69K

-12.05%-279K

11.76%-60K

-10.87%-51K

-29.33%-97K

-18.33%-71K

-58.60%-249K

-17.24%-68K

-6.98%-46K

-134.38%-75K

Change In working capital

-118.24%-581K

-108.29%-2.83M

-113.16%-6.05M

111.69%1.6M

-266.38%-1.56M

268.75%3.19M

214.78%34.11M

6,216.35%45.98M

-1,030.77%-13.67M

131.18%937K

-Change in receivables

-41.10%758K

164.20%1.59M

-101.17%-557K

105.65%2.83M

-1,758.49%-1.97M

2,398.21%1.29M

-433.56%-2.48M

4,797.64%47.75M

-5,088.08%-50.07M

-19.10%-106K

-Change in prepaid assets

-60.36%463K

282.28%3.39M

164.83%446K

90.36%-273K

193.26%2.04M

20.91%1.17M

35.05%-1.86M

-140.52%-688K

-1,118.71%-2.83M

115.66%697K

-Change in payables and accrued expense

0.11%-915K

-76.36%334K

-23.78%-4.76M

-9.45%4.49M

422.68%1.52M

-10,277.78%-916K

-12.67%1.41M

-698.44%-3.85M

2,030.35%4.96M

-67.49%291K

-Change in other current liabilities

-153.86%-887K

-330.98%-8.14M

-144.27%-1.18M

-625.70%-5.45M

-588.99%-3.15M

70.32%1.65M

-75.48%3.52M

316.87%2.66M

-190.05%-751K

213.11%645K

-Change in other working capital

----

1,207.40%33.51M

107.79%106K

3,286.17%35.02M

-235.94%-590K

Cash from discontinued investing activities

Operating cash flow

86.50%-1.13M

-1,063.94%-38.97M

-128.32%-10.12M

48.05%-7.45M

-34.41%-13.07M

-9.27%-8.34M

114.11%4.04M

580.70%35.74M

-75.38%-14.34M

-13.88%-9.72M

Investing cash flow

Cash flow from continuing investing activities

-90.65%718K

-288.69%-17.64M

-109.88%-8.69M

-355.95%-16.85M

-93.66%224K

127.74%7.68M

121.46%9.35M

-404.14%-4.14M

115.47%6.58M

44,237.50%3.53M

Net PPE purchase and sale

117.80%89K

-24.36%-730K

--0

-124.00%-6K

-833.33%-224K

-54.80%-500K

23.17%-587K

-57.74%-265K

105.92%25K

-200.00%-24K

Net investment purchase and sale

-92.31%629K

-270.19%-16.91M

-124.24%-8.69M

-356.83%-16.84M

-87.40%448K

121.36%8.18M

123.22%9.93M

-493.26%-3.87M

115.57%6.56M

--3.56M

Cash from discontinued investing activities

Investing cash flow

-90.65%718K

-288.69%-17.64M

-109.88%-8.69M

-355.95%-16.85M

-93.66%224K

127.74%7.68M

121.46%9.35M

-404.14%-4.14M

115.47%6.58M

44,237.50%3.53M

Financing cash flow

Cash flow from continuing financing activities

-301.77%-571K

-1,025.00%-180K

-1,857.14%-137K

-536.11%-157K

-135.93%-97K

-99.81%283K

90.12%-16K

-103.24%-7K

-98.53%36K

Net issuance payments of debt

91.75%-8K

-313.06%-571K

-1,025.00%-180K

-1,857.14%-137K

-847.62%-157K

-135.93%-97K

-21.18%268K

90.12%-16K

-103.24%-7K

-89.60%21K

Net common stock issuance

----

--0

----

--0

----

Net preferred stock issuance

----

--0

----

--0

----

Proceeds from stock option exercised by employees

--8K

--0

--15K

--0

----

Cash from discontinued financing activities

Financing cash flow

--0

-301.77%-571K

-1,025.00%-180K

-1,857.14%-137K

-536.11%-157K

-135.93%-97K

-99.81%283K

90.06%-16K

-103.24%-7K

-98.53%36K

Net cash flow

Beginning cash position

-55.92%44.23M

10.41%100.33M

-2.59%62.66M

15.47%87.61M

17.36%100.6M

10.41%100.33M

474.47%90.87M

-35.90%64.33M

-50.31%75.87M

-45.83%85.72M

Current changes in cash

46.09%-407K

-518.21%-57.18M

-160.12%-18.99M

-214.60%-24.44M

-111.25%-13M

81.06%-755K

-82.69%13.67M

475.24%31.58M

84.62%-7.77M

-0.90%-6.15M

Effect of exchange rate changes

-162.09%-637K

125.57%1.08M

-87.45%555K

86.57%-506K

100.03%1K

188.52%1.03M

-7.43%-4.21M

508.97%4.42M

-109.51%-3.77M

-800.00%-3.7M

End cash Position

-57.07%43.19M

-55.92%44.23M

-2.59%62.66M

15.47%87.61M

17.36%100.6M

10.41%100.33M

-35.90%64.33M

-50.31%75.87M

Free cash flow

87.27%-1.13M

-1,248.78%-39.7M

-128.53%-10.12M

47.92%-7.46M

-36.38%-13.29M

-11.12%-8.84M

111.75%3.46M

566.59%35.47M

-66.48%-14.32M

-14.06%-9.74M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022	(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	86.50%-1.13M	-1,063.94%-38.97M	-128.32%-10.12M	48.05%-7.45M	-34.41%-13.07M	-9.27%-8.34M	114.11%4.04M	580.70%35.74M	-75.40%-14.34M	-13.87%-9.72M
Net income from continuing operations	96.51%-484K	-31.70%-41.7M	56.65%-6.44M	-993.79%-8.79M	-56.95%-12.6M	-42.06%-13.87M	24.98%-31.66M	-81.92%-14.85M	114.27%983K	-8.09%-8.03M
Operating gains losses	-169.48%-658K	148.31%1.41M	-52.06%1.84M	54.99%-1.13M	92.22%-244K	185.16%947K	-43.28%-2.92M	389.81%3.84M	-53.63%-2.52M	-506.22%-3.14M
Depreciation and amortization	-21.09%247K	63.64%1.28M	29.89%352K	89.29%318K	69.54%295K	86.31%313K	39.96%781K	88.19%271K	11.26%168K	29.85%174K
Deferred tax	2.82%-69K	-12.05%-279K	11.76%-60K	-10.87%-51K	-29.33%-97K	-18.33%-71K	-58.60%-249K	-17.24%-68K	-6.98%-46K	-134.38%-75K
Change In working capital	-118.24%-581K	-108.29%-2.83M	-113.16%-6.05M	111.69%1.6M	-266.38%-1.56M	268.75%3.19M	214.78%34.11M	6,216.35%45.98M	-1,030.77%-13.67M	131.18%937K
-Change in receivables	-41.10%758K	164.20%1.59M	-101.17%-557K	105.65%2.83M	-1,758.49%-1.97M	2,398.21%1.29M	-433.56%-2.48M	4,797.64%47.75M	-5,088.08%-50.07M	-19.10%-106K
-Change in prepaid assets	-60.36%463K	282.28%3.39M	164.83%446K	90.36%-273K	193.26%2.04M	20.91%1.17M	35.05%-1.86M	-140.52%-688K	-1,118.71%-2.83M	115.66%697K
-Change in payables and accrued expense	0.11%-915K	-76.36%334K	-23.78%-4.76M	-9.45%4.49M	422.68%1.52M	-10,277.78%-916K	-12.67%1.41M	-698.44%-3.85M	2,030.35%4.96M	-67.49%291K
-Change in other current liabilities	-153.86%-887K	-330.98%-8.14M	-144.27%-1.18M	-625.70%-5.45M	-588.99%-3.15M	70.32%1.65M	-75.48%3.52M	316.87%2.66M	-190.05%-751K	213.11%645K
-Change in other working capital	----	----	----	----	----	----	1,207.40%33.51M	107.79%106K	3,286.17%35.02M	-235.94%-590K
Cash from discontinued investing activities
Operating cash flow	86.50%-1.13M	-1,063.94%-38.97M	-128.32%-10.12M	48.05%-7.45M	-34.41%-13.07M	-9.27%-8.34M	114.11%4.04M	580.70%35.74M	-75.38%-14.34M	-13.88%-9.72M
Investing cash flow
Cash flow from continuing investing activities	-90.65%718K	-288.69%-17.64M	-109.88%-8.69M	-355.95%-16.85M	-93.66%224K	127.74%7.68M	121.46%9.35M	-404.14%-4.14M	115.47%6.58M	44,237.50%3.53M
Net PPE purchase and sale	117.80%89K	-24.36%-730K	--0	-124.00%-6K	-833.33%-224K	-54.80%-500K	23.17%-587K	-57.74%-265K	105.92%25K	-200.00%-24K
Net investment purchase and sale	-92.31%629K	-270.19%-16.91M	-124.24%-8.69M	-356.83%-16.84M	-87.40%448K	121.36%8.18M	123.22%9.93M	-493.26%-3.87M	115.57%6.56M	--3.56M
Cash from discontinued investing activities
Investing cash flow	-90.65%718K	-288.69%-17.64M	-109.88%-8.69M	-355.95%-16.85M	-93.66%224K	127.74%7.68M	121.46%9.35M	-404.14%-4.14M	115.47%6.58M	44,237.50%3.53M
Financing cash flow
Cash flow from continuing financing activities	0	-301.77%-571K	-1,025.00%-180K	-1,857.14%-137K	-536.11%-157K	-135.93%-97K	-99.81%283K	90.12%-16K	-103.24%-7K	-98.53%36K
Net issuance payments of debt	91.75%-8K	-313.06%-571K	-1,025.00%-180K	-1,857.14%-137K	-847.62%-157K	-135.93%-97K	-21.18%268K	90.12%-16K	-103.24%-7K	-89.60%21K
Net common stock issuance	----	--0	----	----	----	----	--0	----	----	----
Net preferred stock issuance	----	--0	----	----	----	----	--0	----	----	----
Proceeds from stock option exercised by employees	--8K	--0	--0	--0	--0	--0	--15K	--0	--0	----
Cash from discontinued financing activities
Financing cash flow	--0	-301.77%-571K	-1,025.00%-180K	-1,857.14%-137K	-536.11%-157K	-135.93%-97K	-99.81%283K	90.06%-16K	-103.24%-7K	-98.53%36K
Net cash flow
Beginning cash position	-55.92%44.23M	10.41%100.33M	-2.59%62.66M	15.47%87.61M	17.36%100.6M	10.41%100.33M	474.47%90.87M	-35.90%64.33M	-50.31%75.87M	-45.83%85.72M
Current changes in cash	46.09%-407K	-518.21%-57.18M	-160.12%-18.99M	-214.60%-24.44M	-111.25%-13M	81.06%-755K	-82.69%13.67M	475.24%31.58M	84.62%-7.77M	-0.90%-6.15M
Effect of exchange rate changes	-162.09%-637K	125.57%1.08M	-87.45%555K	86.57%-506K	100.03%1K	188.52%1.03M	-7.43%-4.21M	508.97%4.42M	-109.51%-3.77M	-800.00%-3.7M
End cash Position	-57.07%43.19M	-55.92%44.23M	-55.92%44.23M	-2.59%62.66M	15.47%87.61M	17.36%100.6M	10.41%100.33M	10.41%100.33M	-35.90%64.33M	-50.31%75.87M
Free cash flow	87.27%-1.13M	-1,248.78%-39.7M	-128.53%-10.12M	47.92%-7.46M	-36.38%-13.29M	-11.12%-8.84M	111.75%3.46M	566.59%35.47M	-66.48%-14.32M	-14.06%-9.74M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	Unqualified Opinion	--	--	--	--	Unqualified Opinion	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall